Lv21
108 积分 2024-03-09 加入
VP1-2025: Datopotamab deruxtecan (Dato-DXd) vs chemotherapy (CT) in previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2–) breast cancer (BC): Final overall survival (OS) from the phase III TROPION-Breast01 trial
6小时前
待确认
ZIF-based boronic acid functionalized metal-organic frameworks for the enrichment of cis-diol-containing luteolin from food samples prior to HPLC
20天前
已完结
The ‘Mr Human Reproduction’ experience
4个月前
已完结
Keeping the Balance: GABAB Receptors in the Developing Brain and Beyond
4个月前
已完结
Cancer incidence and mortality in China, 2022
4个月前
已完结
Glycogen metabolism and structure: A review
5个月前
已完结
Review of polysaccharide particle-based functional drug delivery
5个月前
已完结
Polysaccharide-based tumor microenvironment-responsive drug delivery systems for cancer therapy
5个月前
已完结
The application of polysaccharide-based nanogels in peptides/proteins and anticancer drugs delivery
5个月前
已完结
Folate receptor-targeted lipid-albumin nanoparticles (F-LAN) for therapeutic delivery of an Akt1 antisense oligonucleotide
5个月前
已完结